XML 37 R22.htm IDEA: XBRL DOCUMENT v3.25.4
Segment Information
9 Months Ended
Jan. 31, 2026
Segment Reporting [Abstract]  
Segment Information Segment Information
In accordance with ASC 280, Segment Reporting, the Company's operations are classified into two business segments: Domestic and International. The Domestic business segment principally designs, manufactures, and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, flexible systems, worksurfaces, workstations, workbenches, and computer enclosures. On November 1, 2024, the Company completed its acquisition of Nu Aire, whose operating results are reflected in the Domestic Operations segment, expanding the Company's Domestic capabilities through its manufacturing of biological safety cabinets, CO2 incubators, ultralow freezers, and other essential laboratory products. See Note C, Nu Aire Acquisition, for further information. The International business segment, which consists of the Company's foreign subsidiaries, provides products and services, including facility design, detailed engineering, construction, and project management from the planning stage through testing and commissioning of laboratories.
The Company's Chief Operating Decision Maker is its CEO, who evaluates the performance of each segment and measures its segment profitability based on earnings before income taxes. Some Corporate expenses, such as those related to executive management, finance, etc., are allocated to the segments. Certain corporate expenses shown below are net of expenses that have been allocated to the business segments. We periodically review these allocations and adjust them based upon changes in business circumstance. Intersegment transactions are recorded at normal profit margins. All intercompany balances and transactions have been eliminated.
The following tables provide financial information by business segment and unallocated corporate expenses for the periods ended January 31, 2026 and 2025 (in thousands):
Domestic
Operations
International
Operations
Corporate /
Eliminations
Total
Three Months Ended January 31, 2026
Revenues from external customers$50,953 $18,446 $— $69,399 
Intersegment revenues463 870 (1,333)— 
Depreciation and amortization
1,479 97 21 1,597 
Interest expense
307 16 789 1,112 
Earnings (loss) before income taxes
2,312 2,351 (3,059)1,604 
Income tax expense (benefit)
22 711 (205)528 
Net earnings attributable to non-controlling interest
— 384 — 384 
Net earnings (loss) attributable to Kewaunee Scientific Corporation
2,290 1,256 (2,854)692 
Segment assets
135,427 40,534 — 175,961 
Expenditures for segment assets
636 32 — 668 
Revenues (excluding intersegment) from customers in foreign countries
4,247 18,446 — 22,693 
Three Months Ended January 31, 2025
Revenues from external customers$51,976 $15,191 $— $67,167 
Intersegment revenues28 943 (971)— 
Depreciation and amortization
1,414 107 42 1,563 
Interest expense
322 26 789 1,137 
Earnings (loss) before income taxes
3,514 786 (3,025)1,275 
Income tax expense (benefit)
638 281 (1,027)(108)
Net earnings attributable to non-controlling interest
— 29 — 29 
Net earnings (loss) attributable to Kewaunee Scientific Corporation
2,876 476 (1,998)1,354 
Segment assets
146,798 42,350 — 189,148 
Expenditures for segment assets
621 68 — 689 
Revenues (excluding intersegment) from customers in foreign countries
3,237 15,191 — 18,428 
Domestic
Operations
International
Operations
Corporate /
Eliminations
Total
Nine Months Ended January 31, 2026
Revenues from external customers$160,529 $50,070 $— $210,599 
Intersegment revenues869 2,561 (3,430)— 
Depreciation and amortization
4,366 292 68 4,726 
Interest expense
931 39 2,261 3,231 
Earnings (loss) before income taxes
13,091 4,518 (8,632)8,977 
Income tax expense (benefit)
2,482 1,435 (1,713)2,204 
Net earnings attributable to non-controlling interest
— 543 — 543 
Net earnings (loss) attributable to Kewaunee Scientific Corporation
10,609 2,540 (6,919)6,230 
Segment assets
135,427 40,534 — 175,961 
Expenditures for segment assets
2,836 173 — 3,009 
Revenues (excluding intersegment) from customers in foreign countries
9,734 50,070 — 59,804 
Nine Months Ended January 31, 2025
Revenues from external customers$123,908 $39,416 $— $163,324 
Intersegment revenues298 2,766 (3,064)— 
Depreciation and amortization
2,736 317 131 3,184 
Interest expense
1,176 66 809 2,051 
Earnings (loss) before income taxes
12,914 2,183 (7,461)7,636 
Income tax expense (benefit)
2,643 807 (2,450)1,000 
Net earnings attributable to non-controlling interest
— 81 — 81 
Net earnings (loss) attributable to Kewaunee Scientific Corporation
10,271 1,295 (5,011)6,555 
Segment assets
146,798 42,350 — 189,148 
Expenditures for segment assets
1,457 193 — 1,650 
Revenues (excluding intersegment) from customers in foreign countries
4,201 39,416 — 43,617